150 related articles for article (PubMed ID: 22235334)
1. BED estimates of HIV incidence: resolving the differences, making things simpler.
Hargrove J; van Schalkwyk C; Eastwood H
PLoS One; 2012; 7(1):e29736. PubMed ID: 22235334
[TBL] [Abstract][Full Text] [Related]
2. How should we best estimate the mean recency duration for the BED method?
Hargrove J; Eastwood H; Mahiane G; van Schalkwyk C
PLoS One; 2012; 7(11):e49661. PubMed ID: 23166743
[TBL] [Abstract][Full Text] [Related]
3. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.
Hargrove JW; Humphrey JH; Mutasa K; Parekh BS; McDougal JS; Ntozini R; Chidawanyika H; Moulton LH; Ward B; Nathoo K; Iliff PJ; Kopp E
AIDS; 2008 Feb; 22(4):511-8. PubMed ID: 18301064
[TBL] [Abstract][Full Text] [Related]
4. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
[TBL] [Abstract][Full Text] [Related]
5. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.
Xu J; Wang H; Jiang Y; Ding G; Jia M; Wang G; Chu J; Smith K; Sharp GB; Chen RY; Jin X; Dong R; Han X; Shang H; Wang N
Int J Infect Dis; 2010 Jul; 14(7):e608-12. PubMed ID: 20102792
[TBL] [Abstract][Full Text] [Related]
6. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 incidence estimates among young Thai men using IgG-capture BED-enzyme immunoassay (BED-CEIA) during 2005-2006.
Kana K; Tabprasit S; Chuenchitra T; Sirisopana N; Rangsin R
J Med Assoc Thai; 2009 Feb; 92 Suppl 1():S112-6. PubMed ID: 21299183
[TBL] [Abstract][Full Text] [Related]
8. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.
McDougal JS; Parekh BS; Peterson ML; Branson BM; Dobbs T; Ackers M; Gurwith M
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):945-52. PubMed ID: 17067263
[TBL] [Abstract][Full Text] [Related]
9. Mixture models for calibrating the BED for HIV incidence testing.
Mahiane SG; Fiamma A; Auvert B
Stat Med; 2014 May; 33(10):1767-83. PubMed ID: 24834521
[TBL] [Abstract][Full Text] [Related]
10. Should biomarker estimates of HIV incidence be adjusted?
Brookmeyer R
AIDS; 2009 Feb; 23(4):485-91. PubMed ID: 19165087
[TBL] [Abstract][Full Text] [Related]
11. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
[TBL] [Abstract][Full Text] [Related]
13. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
[TBL] [Abstract][Full Text] [Related]
14. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
[TBL] [Abstract][Full Text] [Related]
15. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.
Marinda ET; Hargrove J; Preiser W; Slabbert H; van Zyl G; Levin J; Moulton LH; Welte A; Humphrey J
J Acquir Immune Defic Syndr; 2010 Apr; 53(4):496-9. PubMed ID: 20306555
[TBL] [Abstract][Full Text] [Related]
16. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
Schüpbach J; Gebhardt MD; Tomasik Z; Niederhauser C; Yerly S; Bürgisser P; Matter L; Gorgievski M; Dubs R; Schultze D; Steffen I; Andreutti C; Martinetti G; Güntert B; Staub R; Daneel S; Vernazza P
PLoS Med; 2007 Dec; 4(12):e343. PubMed ID: 18052604
[TBL] [Abstract][Full Text] [Related]
17. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
[TBL] [Abstract][Full Text] [Related]
18. The Recency Period for Estimation of Human Immunodeficiency Virus Incidence by the AxSYM Avidity Assay and BED-Capture Enzyme Immunoassay in the Republic of Korea.
Yu HK; Heo TY; Kim NY; Wang JS; Lee JK; Kim SS; Kee MK
Osong Public Health Res Perspect; 2014 Aug; 5(4):187-92. PubMed ID: 25379368
[TBL] [Abstract][Full Text] [Related]
19. HIV incidence determination in the United States: a multiassay approach.
Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
[TBL] [Abstract][Full Text] [Related]
20. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
